Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NKX2-2
|
ENSG00000125820.5 | NK2 homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NKX2-2 | hg19_v2_chr20_-_21494654_21494678 | 0.09 | 6.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_61513146 | 3.95 |
ENST00000430431.1
|
LINC00948
|
long intergenic non-protein coding RNA 948 |
chr10_-_61513201 | 3.09 |
ENST00000414264.1
ENST00000594536.1 |
LINC00948
|
long intergenic non-protein coding RNA 948 |
chr1_+_104293028 | 3.02 |
ENST00000370079.3
|
AMY1C
|
amylase, alpha 1C (salivary) |
chr2_+_228736321 | 2.59 |
ENST00000309931.2
|
DAW1
|
dynein assembly factor with WDR repeat domains 1 |
chr1_+_54359854 | 2.50 |
ENST00000361921.3
ENST00000322679.6 ENST00000532493.1 ENST00000525202.1 ENST00000524406.1 ENST00000388876.3 |
DIO1
|
deiodinase, iodothyronine, type I |
chr1_+_104159999 | 2.39 |
ENST00000414303.2
ENST00000423678.1 |
AMY2A
|
amylase, alpha 2A (pancreatic) |
chr1_+_78769549 | 2.29 |
ENST00000370758.1
|
PTGFR
|
prostaglandin F receptor (FP) |
chr15_-_56757329 | 2.19 |
ENST00000260453.3
|
MNS1
|
meiosis-specific nuclear structural 1 |
chr13_-_36429763 | 2.14 |
ENST00000379893.1
|
DCLK1
|
doublecortin-like kinase 1 |
chr12_-_49582978 | 2.09 |
ENST00000301071.7
|
TUBA1A
|
tubulin, alpha 1a |
chr1_-_26633067 | 1.93 |
ENST00000421827.2
ENST00000374215.1 ENST00000374223.1 ENST00000357089.4 ENST00000535108.1 ENST00000314675.7 ENST00000436301.2 ENST00000423664.1 ENST00000374221.3 |
UBXN11
|
UBX domain protein 11 |
chr13_+_31506818 | 1.79 |
ENST00000380473.3
|
TEX26
|
testis expressed 26 |
chr17_+_7591639 | 1.70 |
ENST00000396463.2
|
WRAP53
|
WD repeat containing, antisense to TP53 |
chr2_+_39103103 | 1.69 |
ENST00000340556.6
ENST00000410014.1 ENST00000409665.1 ENST00000409077.2 ENST00000409131.2 |
MORN2
|
MORN repeat containing 2 |
chr17_+_7591747 | 1.69 |
ENST00000534050.1
|
WRAP53
|
WD repeat containing, antisense to TP53 |
chr12_-_68696652 | 1.67 |
ENST00000539972.1
|
MDM1
|
Mdm1 nuclear protein homolog (mouse) |
chr13_-_61989655 | 1.67 |
ENST00000409204.4
|
PCDH20
|
protocadherin 20 |
chr12_-_71551652 | 1.60 |
ENST00000546561.1
|
TSPAN8
|
tetraspanin 8 |
chr17_-_29641084 | 1.52 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr3_-_121379739 | 1.50 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr1_-_216978709 | 1.47 |
ENST00000360012.3
|
ESRRG
|
estrogen-related receptor gamma |
chr1_-_54405773 | 1.45 |
ENST00000371376.1
|
HSPB11
|
heat shock protein family B (small), member 11 |
chr5_+_140602904 | 1.42 |
ENST00000515856.2
ENST00000239449.4 |
PCDHB14
|
protocadherin beta 14 |
chr8_-_133637624 | 1.25 |
ENST00000522789.1
|
LRRC6
|
leucine rich repeat containing 6 |
chr8_-_133772794 | 1.23 |
ENST00000519187.1
ENST00000523829.1 ENST00000356838.3 ENST00000377901.4 ENST00000519304.1 |
TMEM71
|
transmembrane protein 71 |
chr16_+_30212378 | 1.21 |
ENST00000569485.1
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
chr7_-_102715263 | 1.21 |
ENST00000379305.3
|
FBXL13
|
F-box and leucine-rich repeat protein 13 |
chr11_+_93063137 | 1.16 |
ENST00000534747.1
|
CCDC67
|
coiled-coil domain containing 67 |
chr9_-_15510287 | 1.14 |
ENST00000397519.2
|
PSIP1
|
PC4 and SFRS1 interacting protein 1 |
chr6_-_110011704 | 1.13 |
ENST00000448084.2
|
AK9
|
adenylate kinase 9 |
chr7_+_23719749 | 1.11 |
ENST00000409192.3
ENST00000344962.4 ENST00000409653.1 ENST00000409994.3 |
FAM221A
|
family with sequence similarity 221, member A |
chr8_+_94767109 | 1.09 |
ENST00000409623.3
ENST00000453906.1 ENST00000521517.1 |
TMEM67
|
transmembrane protein 67 |
chr1_-_160231451 | 1.08 |
ENST00000495887.1
|
DCAF8
|
DDB1 and CUL4 associated factor 8 |
chr1_+_171217622 | 1.04 |
ENST00000433267.1
ENST00000367750.3 |
FMO1
|
flavin containing monooxygenase 1 |
chr7_-_102715172 | 1.03 |
ENST00000456695.1
ENST00000455112.2 ENST00000440067.1 |
FBXL13
|
F-box and leucine-rich repeat protein 13 |
chr6_-_110011718 | 1.03 |
ENST00000532976.1
|
AK9
|
adenylate kinase 9 |
chr4_+_36283213 | 0.99 |
ENST00000357504.3
|
DTHD1
|
death domain containing 1 |
chr3_-_150920979 | 0.97 |
ENST00000309180.5
ENST00000480322.1 |
GPR171
|
G protein-coupled receptor 171 |
chrX_-_154033661 | 0.95 |
ENST00000393531.1
|
MPP1
|
membrane protein, palmitoylated 1, 55kDa |
chr2_+_120301997 | 0.92 |
ENST00000602047.1
|
PCDP1
|
Primary ciliary dyskinesia protein 1 |
chr3_-_170744498 | 0.92 |
ENST00000382808.4
ENST00000314251.3 |
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2 |
chr10_-_112678692 | 0.91 |
ENST00000605742.1
|
BBIP1
|
BBSome interacting protein 1 |
chr2_+_170655322 | 0.89 |
ENST00000260956.4
ENST00000417292.1 |
SSB
|
Sjogren syndrome antigen B (autoantigen La) |
chr7_-_130080977 | 0.85 |
ENST00000223208.5
|
CEP41
|
centrosomal protein 41kDa |
chr6_-_80247105 | 0.84 |
ENST00000369846.4
|
LCA5
|
Leber congenital amaurosis 5 |
chr21_+_25801041 | 0.83 |
ENST00000453784.2
ENST00000423581.1 |
AP000476.1
|
AP000476.1 |
chr5_-_41261540 | 0.80 |
ENST00000263413.3
|
C6
|
complement component 6 |
chr1_+_211433275 | 0.79 |
ENST00000367005.4
|
RCOR3
|
REST corepressor 3 |
chr3_-_122134882 | 0.79 |
ENST00000330689.4
|
WDR5B
|
WD repeat domain 5B |
chr6_+_159084188 | 0.79 |
ENST00000367081.3
|
SYTL3
|
synaptotagmin-like 3 |
chr13_-_20357110 | 0.76 |
ENST00000427943.1
|
PSPC1
|
paraspeckle component 1 |
chr4_+_128802016 | 0.76 |
ENST00000270861.5
ENST00000515069.1 ENST00000513090.1 ENST00000507249.1 |
PLK4
|
polo-like kinase 4 |
chr4_-_105416039 | 0.75 |
ENST00000394767.2
|
CXXC4
|
CXXC finger protein 4 |
chr4_+_95679072 | 0.75 |
ENST00000515059.1
|
BMPR1B
|
bone morphogenetic protein receptor, type IB |
chr5_+_159656437 | 0.74 |
ENST00000402432.3
|
FABP6
|
fatty acid binding protein 6, ileal |
chr6_-_80247140 | 0.73 |
ENST00000392959.1
ENST00000467898.3 |
LCA5
|
Leber congenital amaurosis 5 |
chr11_+_65266507 | 0.72 |
ENST00000544868.1
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
chr7_-_120497178 | 0.70 |
ENST00000441017.1
ENST00000424710.1 ENST00000433758.1 |
TSPAN12
|
tetraspanin 12 |
chr14_-_89878369 | 0.69 |
ENST00000553840.1
ENST00000556916.1 |
FOXN3
|
forkhead box N3 |
chr16_-_21289627 | 0.66 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
chr11_-_72432950 | 0.66 |
ENST00000426523.1
ENST00000429686.1 |
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr6_-_150212029 | 0.66 |
ENST00000529948.1
ENST00000357183.4 ENST00000367363.3 |
RAET1E
|
retinoic acid early transcript 1E |
chr9_-_20622478 | 0.62 |
ENST00000355930.6
ENST00000380338.4 |
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr4_-_110723335 | 0.62 |
ENST00000394634.2
|
CFI
|
complement factor I |
chrX_+_47092314 | 0.60 |
ENST00000218348.3
|
USP11
|
ubiquitin specific peptidase 11 |
chr17_-_29641104 | 0.60 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr20_-_55841398 | 0.58 |
ENST00000395864.3
|
BMP7
|
bone morphogenetic protein 7 |
chr16_+_53241854 | 0.57 |
ENST00000565803.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
chr8_+_76452097 | 0.57 |
ENST00000396423.2
|
HNF4G
|
hepatocyte nuclear factor 4, gamma |
chr3_+_158991025 | 0.55 |
ENST00000337808.6
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
chr16_+_30212050 | 0.55 |
ENST00000563322.1
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
chrX_-_70474910 | 0.54 |
ENST00000373988.1
ENST00000373998.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
chr6_+_140175987 | 0.53 |
ENST00000414038.1
ENST00000431609.1 |
RP5-899B16.1
|
RP5-899B16.1 |
chr11_+_94277017 | 0.52 |
ENST00000358752.2
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) |
chr9_-_99382065 | 0.50 |
ENST00000265659.2
ENST00000375241.1 ENST00000375236.1 |
CDC14B
|
cell division cycle 14B |
chr1_-_207095324 | 0.50 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr1_+_84630367 | 0.49 |
ENST00000370680.1
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr12_+_41831485 | 0.48 |
ENST00000539469.2
ENST00000298919.7 |
PDZRN4
|
PDZ domain containing ring finger 4 |
chr2_+_162272605 | 0.48 |
ENST00000389554.3
|
TBR1
|
T-box, brain, 1 |
chr2_-_239198743 | 0.47 |
ENST00000440245.1
ENST00000431832.1 |
PER2
|
period circadian clock 2 |
chrX_-_70474499 | 0.47 |
ENST00000353904.2
|
ZMYM3
|
zinc finger, MYM-type 3 |
chr12_+_57998400 | 0.47 |
ENST00000548804.1
ENST00000550596.1 ENST00000551835.1 ENST00000549583.1 |
DTX3
|
deltex homolog 3 (Drosophila) |
chr1_-_223308098 | 0.46 |
ENST00000342210.6
|
TLR5
|
toll-like receptor 5 |
chr7_+_114055052 | 0.44 |
ENST00000462331.1
ENST00000408937.3 ENST00000403559.4 ENST00000350908.4 ENST00000393498.2 ENST00000393495.3 ENST00000378237.3 ENST00000393489.3 |
FOXP2
|
forkhead box P2 |
chr12_+_20963632 | 0.44 |
ENST00000540853.1
ENST00000261196.2 |
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr5_+_82767583 | 0.44 |
ENST00000512590.2
ENST00000513960.1 ENST00000513984.1 ENST00000502527.2 |
VCAN
|
versican |
chr5_+_82767487 | 0.44 |
ENST00000343200.5
ENST00000342785.4 |
VCAN
|
versican |
chr12_+_20963647 | 0.44 |
ENST00000381545.3
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr10_-_27529486 | 0.44 |
ENST00000375888.1
|
ACBD5
|
acyl-CoA binding domain containing 5 |
chr8_-_122653630 | 0.43 |
ENST00000303924.4
|
HAS2
|
hyaluronan synthase 2 |
chrX_+_11777671 | 0.43 |
ENST00000380693.3
ENST00000380692.2 |
MSL3
|
male-specific lethal 3 homolog (Drosophila) |
chr9_-_39239171 | 0.40 |
ENST00000358144.2
|
CNTNAP3
|
contactin associated protein-like 3 |
chr1_+_61547894 | 0.39 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr1_-_45253377 | 0.39 |
ENST00000372207.3
|
BEST4
|
bestrophin 4 |
chr1_-_227505289 | 0.38 |
ENST00000366765.3
|
CDC42BPA
|
CDC42 binding protein kinase alpha (DMPK-like) |
chr3_-_114790179 | 0.38 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr2_-_163008903 | 0.37 |
ENST00000418842.2
ENST00000375497.3 |
GCG
|
glucagon |
chr3_+_108541545 | 0.36 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr1_-_197169672 | 0.36 |
ENST00000367405.4
|
ZBTB41
|
zinc finger and BTB domain containing 41 |
chr1_-_213188772 | 0.36 |
ENST00000544555.1
|
ANGEL2
|
angel homolog 2 (Drosophila) |
chr3_-_69101461 | 0.36 |
ENST00000543976.1
|
TMF1
|
TATA element modulatory factor 1 |
chr7_-_99149715 | 0.36 |
ENST00000449309.1
|
FAM200A
|
family with sequence similarity 200, member A |
chr1_+_43312258 | 0.35 |
ENST00000372508.3
ENST00000372507.1 ENST00000372506.1 ENST00000397044.3 ENST00000372504.1 |
ZNF691
|
zinc finger protein 691 |
chr8_+_71485681 | 0.35 |
ENST00000391684.1
|
AC120194.1
|
AC120194.1 |
chr1_-_115259337 | 0.35 |
ENST00000369535.4
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog |
chr14_-_24020858 | 0.34 |
ENST00000419474.3
|
ZFHX2
|
zinc finger homeobox 2 |
chr1_+_15272271 | 0.33 |
ENST00000400797.3
|
KAZN
|
kazrin, periplakin interacting protein |
chr2_+_120436733 | 0.33 |
ENST00000401466.1
ENST00000424086.1 ENST00000272521.6 |
TMEM177
|
transmembrane protein 177 |
chr13_-_20357057 | 0.32 |
ENST00000338910.4
|
PSPC1
|
paraspeckle component 1 |
chr3_+_179280668 | 0.31 |
ENST00000429709.2
ENST00000450518.2 ENST00000392662.1 ENST00000490364.1 |
ACTL6A
|
actin-like 6A |
chr7_-_122339162 | 0.31 |
ENST00000340112.2
|
RNF133
|
ring finger protein 133 |
chr19_+_58193388 | 0.30 |
ENST00000596085.1
ENST00000594684.1 |
ZNF551
AC003006.7
|
zinc finger protein 551 Uncharacterized protein |
chr19_-_14945933 | 0.30 |
ENST00000322301.3
|
OR7A5
|
olfactory receptor, family 7, subfamily A, member 5 |
chr14_-_100841930 | 0.30 |
ENST00000555031.1
ENST00000553395.1 ENST00000553545.1 ENST00000344102.5 ENST00000556338.1 ENST00000392882.2 ENST00000553934.1 |
WARS
|
tryptophanyl-tRNA synthetase |
chr17_+_53342311 | 0.29 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
chr8_+_110552337 | 0.29 |
ENST00000337573.5
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9 |
chr20_-_55841662 | 0.29 |
ENST00000395863.3
ENST00000450594.2 |
BMP7
|
bone morphogenetic protein 7 |
chrX_+_36053908 | 0.28 |
ENST00000378660.2
|
CHDC2
|
calponin homology domain containing 2 |
chrX_-_70474377 | 0.28 |
ENST00000373978.1
ENST00000373981.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
chr14_-_44976474 | 0.28 |
ENST00000340446.4
|
FSCB
|
fibrous sheath CABYR binding protein |
chr3_-_33686743 | 0.28 |
ENST00000333778.6
ENST00000539981.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
chr7_+_150065278 | 0.28 |
ENST00000519397.1
ENST00000479668.1 ENST00000540729.1 |
REPIN1
|
replication initiator 1 |
chr9_-_85882145 | 0.28 |
ENST00000328788.1
|
FRMD3
|
FERM domain containing 3 |
chr12_+_510742 | 0.28 |
ENST00000239830.4
|
CCDC77
|
coiled-coil domain containing 77 |
chr18_+_29671812 | 0.27 |
ENST00000261593.3
ENST00000578914.1 |
RNF138
|
ring finger protein 138, E3 ubiquitin protein ligase |
chr15_+_65843130 | 0.27 |
ENST00000569894.1
|
PTPLAD1
|
protein tyrosine phosphatase-like A domain containing 1 |
chr10_+_97759848 | 0.27 |
ENST00000424464.1
ENST00000410012.2 ENST00000344386.3 |
CC2D2B
|
coiled-coil and C2 domain containing 2B |
chr8_+_110552831 | 0.26 |
ENST00000530629.1
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9 |
chr12_+_510795 | 0.26 |
ENST00000412006.2
|
CCDC77
|
coiled-coil domain containing 77 |
chr5_+_167718604 | 0.26 |
ENST00000265293.4
|
WWC1
|
WW and C2 domain containing 1 |
chr2_+_113299990 | 0.26 |
ENST00000537335.1
ENST00000417433.2 |
POLR1B
|
polymerase (RNA) I polypeptide B, 128kDa |
chr1_-_246670519 | 0.26 |
ENST00000388985.4
ENST00000490107.1 |
SMYD3
|
SET and MYND domain containing 3 |
chr1_+_180601139 | 0.25 |
ENST00000367590.4
ENST00000367589.3 |
XPR1
|
xenotropic and polytropic retrovirus receptor 1 |
chr13_+_102104980 | 0.25 |
ENST00000545560.2
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr8_-_124279627 | 0.25 |
ENST00000357082.4
|
ZHX1-C8ORF76
|
ZHX1-C8ORF76 readthrough |
chr14_-_100841670 | 0.25 |
ENST00000557297.1
ENST00000555813.1 ENST00000557135.1 ENST00000556698.1 ENST00000554509.1 ENST00000555410.1 |
WARS
|
tryptophanyl-tRNA synthetase |
chr12_-_58240470 | 0.24 |
ENST00000548823.1
ENST00000398073.2 |
CTDSP2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
chr12_-_42631529 | 0.24 |
ENST00000548917.1
|
YAF2
|
YY1 associated factor 2 |
chrX_+_105445717 | 0.24 |
ENST00000372552.1
|
MUM1L1
|
melanoma associated antigen (mutated) 1-like 1 |
chr1_-_207095212 | 0.24 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chrX_-_70473957 | 0.24 |
ENST00000373984.3
ENST00000314425.5 ENST00000373982.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
chr17_-_67138015 | 0.24 |
ENST00000284425.2
ENST00000590645.1 |
ABCA6
|
ATP-binding cassette, sub-family A (ABC1), member 6 |
chr16_-_20556492 | 0.23 |
ENST00000568098.1
|
ACSM2B
|
acyl-CoA synthetase medium-chain family member 2B |
chr1_+_241695424 | 0.23 |
ENST00000366558.3
ENST00000366559.4 |
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr18_-_52989217 | 0.23 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chr15_+_79165296 | 0.23 |
ENST00000558746.1
ENST00000558830.1 ENST00000559345.1 |
MORF4L1
|
mortality factor 4 like 1 |
chr5_-_58652788 | 0.23 |
ENST00000405755.2
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr15_+_79165372 | 0.23 |
ENST00000558502.1
|
MORF4L1
|
mortality factor 4 like 1 |
chrX_+_83116142 | 0.23 |
ENST00000329312.4
|
CYLC1
|
cylicin, basic protein of sperm head cytoskeleton 1 |
chr17_-_43339474 | 0.23 |
ENST00000331780.4
|
SPATA32
|
spermatogenesis associated 32 |
chr1_-_226926864 | 0.22 |
ENST00000429204.1
ENST00000366784.1 |
ITPKB
|
inositol-trisphosphate 3-kinase B |
chr3_+_88188254 | 0.22 |
ENST00000309495.5
|
ZNF654
|
zinc finger protein 654 |
chr3_+_23847432 | 0.22 |
ENST00000346855.3
|
UBE2E1
|
ubiquitin-conjugating enzyme E2E 1 |
chr15_+_42841008 | 0.22 |
ENST00000260372.3
ENST00000568876.1 ENST00000568846.2 ENST00000562398.1 |
HAUS2
|
HAUS augmin-like complex, subunit 2 |
chr14_+_39703112 | 0.22 |
ENST00000555143.1
ENST00000280082.3 |
MIA2
|
melanoma inhibitory activity 2 |
chr11_-_72433346 | 0.22 |
ENST00000334211.8
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chrX_+_152953505 | 0.22 |
ENST00000253122.5
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8 |
chr2_+_202937972 | 0.21 |
ENST00000541917.1
ENST00000295844.3 |
AC079354.1
|
uncharacterized protein KIAA2012 |
chr9_-_95166841 | 0.21 |
ENST00000262551.4
|
OGN
|
osteoglycin |
chr15_+_79165151 | 0.21 |
ENST00000331268.5
|
MORF4L1
|
mortality factor 4 like 1 |
chr22_-_24093267 | 0.21 |
ENST00000341976.3
|
ZNF70
|
zinc finger protein 70 |
chr3_-_123339418 | 0.21 |
ENST00000583087.1
|
MYLK
|
myosin light chain kinase |
chr3_-_123339343 | 0.21 |
ENST00000578202.1
|
MYLK
|
myosin light chain kinase |
chr17_+_48823975 | 0.21 |
ENST00000513969.1
ENST00000503728.1 |
LUC7L3
|
LUC7-like 3 (S. cerevisiae) |
chr16_+_22501658 | 0.21 |
ENST00000415833.2
|
NPIPB5
|
nuclear pore complex interacting protein family, member B5 |
chr17_+_39261584 | 0.20 |
ENST00000391415.1
|
KRTAP4-9
|
keratin associated protein 4-9 |
chr3_-_33686925 | 0.20 |
ENST00000485378.2
ENST00000313350.6 ENST00000487200.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
chr9_-_95166884 | 0.20 |
ENST00000375561.5
|
OGN
|
osteoglycin |
chr13_-_36944307 | 0.20 |
ENST00000355182.4
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome) |
chr15_-_60690163 | 0.19 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
chr3_+_23847394 | 0.19 |
ENST00000306627.3
|
UBE2E1
|
ubiquitin-conjugating enzyme E2E 1 |
chr20_-_13765526 | 0.19 |
ENST00000202816.1
|
ESF1
|
ESF1, nucleolar pre-rRNA processing protein, homolog (S. cerevisiae) |
chr9_+_71944241 | 0.19 |
ENST00000257515.8
|
FAM189A2
|
family with sequence similarity 189, member A2 |
chr17_+_52978107 | 0.18 |
ENST00000445275.2
|
TOM1L1
|
target of myb1 (chicken)-like 1 |
chr8_-_134072593 | 0.18 |
ENST00000427060.2
|
SLA
|
Src-like-adaptor |
chr15_+_79165222 | 0.18 |
ENST00000559930.1
|
MORF4L1
|
mortality factor 4 like 1 |
chr17_-_15469590 | 0.18 |
ENST00000312127.2
|
CDRT1
|
CMT duplicated region transcript 1; Uncharacterized protein |
chrX_-_130037198 | 0.18 |
ENST00000370935.1
ENST00000338144.3 ENST00000394363.1 |
ENOX2
|
ecto-NOX disulfide-thiol exchanger 2 |
chr3_-_69101413 | 0.18 |
ENST00000398559.2
|
TMF1
|
TATA element modulatory factor 1 |
chr2_-_25565377 | 0.17 |
ENST00000264709.3
ENST00000406659.3 |
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
chr6_+_45296391 | 0.16 |
ENST00000371436.6
ENST00000576263.1 |
RUNX2
|
runt-related transcription factor 2 |
chr13_+_50656307 | 0.16 |
ENST00000378180.4
|
DLEU1
|
deleted in lymphocytic leukemia 1 (non-protein coding) |
chr16_+_10837643 | 0.16 |
ENST00000574334.1
ENST00000283027.5 ENST00000433392.2 |
NUBP1
|
nucleotide binding protein 1 |
chr9_+_92219919 | 0.16 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
chr14_+_22948510 | 0.16 |
ENST00000390483.1
|
TRAJ56
|
T cell receptor alpha joining 56 |
chr5_+_125758813 | 0.16 |
ENST00000285689.3
ENST00000515200.1 |
GRAMD3
|
GRAM domain containing 3 |
chr5_-_58571935 | 0.16 |
ENST00000503258.1
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr8_-_18666360 | 0.16 |
ENST00000286485.8
|
PSD3
|
pleckstrin and Sec7 domain containing 3 |
chr2_-_75938115 | 0.15 |
ENST00000321027.3
|
GCFC2
|
GC-rich sequence DNA-binding factor 2 |
chr1_+_110577229 | 0.15 |
ENST00000369795.3
ENST00000369794.2 |
STRIP1
|
striatin interacting protein 1 |
chr5_+_125758865 | 0.15 |
ENST00000542322.1
ENST00000544396.1 |
GRAMD3
|
GRAM domain containing 3 |
chr9_-_97356075 | 0.15 |
ENST00000375337.3
|
FBP2
|
fructose-1,6-bisphosphatase 2 |
chr11_-_77850629 | 0.15 |
ENST00000376156.3
ENST00000525870.1 ENST00000530454.1 ENST00000525755.1 ENST00000527099.1 ENST00000525761.1 ENST00000299626.5 |
ALG8
|
ALG8, alpha-1,3-glucosyltransferase |
chr12_-_371994 | 0.15 |
ENST00000343164.4
ENST00000436453.1 ENST00000445055.2 ENST00000546319.1 |
SLC6A13
|
solute carrier family 6 (neurotransmitter transporter), member 13 |
chr15_+_54305101 | 0.14 |
ENST00000260323.11
ENST00000545554.1 ENST00000537900.1 |
UNC13C
|
unc-13 homolog C (C. elegans) |
chr2_+_103035102 | 0.14 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chrX_+_108779004 | 0.14 |
ENST00000218004.1
|
NXT2
|
nuclear transport factor 2-like export factor 2 |
chrX_+_100743031 | 0.14 |
ENST00000423738.3
|
ARMCX4
|
armadillo repeat containing, X-linked 4 |
chr11_+_93479588 | 0.13 |
ENST00000526335.1
|
C11orf54
|
chromosome 11 open reading frame 54 |
chr12_+_52056548 | 0.13 |
ENST00000545061.1
ENST00000355133.3 |
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.7 | 2.2 | GO:0061566 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.3 | 2.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.3 | 2.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.8 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.2 | 0.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 0.9 | GO:1905069 | allantois development(GO:1905069) |
0.2 | 0.8 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.2 | 3.6 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 2.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.2 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.8 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.1 | 0.7 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.4 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 1.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 1.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.5 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.1 | 0.5 | GO:0051941 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.1 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 1.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 3.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.2 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.5 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 2.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.2 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.0 | 1.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 1.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.5 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.2 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.0 | 0.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.0 | 0.1 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.5 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.0 | 0.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.1 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.0 | 0.1 | GO:0032268 | regulation of cellular protein metabolic process(GO:0032268) |
0.0 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.9 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.0 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 2.6 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.4 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 1.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.0 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.0 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.0 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.0 | 2.1 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 3.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0043159 | cytoskeletal calyx(GO:0033150) acrosomal matrix(GO:0043159) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.2 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 1.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 1.2 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 2.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 2.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 1.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 1.4 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 1.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.6 | 2.4 | GO:0016160 | amylase activity(GO:0016160) |
0.4 | 2.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.8 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.2 | 0.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 2.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 1.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.7 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 3.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 1.1 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.0 | 1.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 2.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 2.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.0 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 2.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 2.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 3.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 2.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |